¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"hypersensitivity pneumonia"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immediate hypersensitivity
    Áï½Ã°ú¹Î(¼º)
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹Î¼º
  • pollen hypersensitivity
    ²É°¡·ç°ú¹Î¼º
  • aspiration pneumonia
    ÈíÀÎÆó·Å
  • atypical pneumonia
    ºñÁ¤ÇüÆó·Å
  • acute pneumonia
    ±Þ¼ºÆó·Å
  • bronchiolitis obliterans-organizing pneumonia
    Æó¼â¼¼±â°üÁö±âÁúÈ­Æó·Å
  • croupous pneumonia
    ¿±Æó·Å
  • desquamative interstitial pneumonia
    ¹Ú¸®»çÀÌÁúÆó·Å, ¹Ú¸®°£ÁúÆó·Å
  • eosinophilic pneumonia
    È£»ê±¸Æó·Å
  • ephemeral pneumonia
    ÀϽüºÆó·Å
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • hypostatic pneumonia
    ħ°­¼ºÆó·Å
  • indurative pneumonia
    °æÈ­Æó·Å
  • inhalation pneumonia
    ÈíÀÔÆó·Å
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • immediate hypersensitivity
    Áï½Ã°ú¹Î
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹Î
  • pollen hypersensitivity
    ²É°¡·ç°ú¹Î
  • tuberculin-type hypersensitivity
    (¢¡delayed-type hypersensitivity) Áö¿¬°ú¹Î
  • aspiration pneumonia
    ÈíÀÎÆó·Å
  • bronchiolitis obliterans-organizing pneumonia
    Æó¼â¼¼±â°üÁö±âÁúÈ­Æó·Å
  • croupous pneumonia
    (¢¡lobar pneumonia) ¿±Æó·Å
  • ephemeral pneumonia
    ÀϽüºÆó·Å
  • giant cell pneumonia
    °Å´ë¼¼Æ÷Æó·Å
  • hypostatic pneumonia
    ħ°­¼ºÆó·Å
  • indurative pneumonia
    °æÈ­Æó·Å
  • inhalation pneumonia
    ÈíÀÔÆó·Å
  • interstitial pneumonia
    °£ÁúÆó·Å, »çÀÌÁúÆó·Å
  • lipid pneumonia
    ÁöÁúÆó·Å
  • lobar pneumonia
    ¿±Æó·Å
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hypersensitivity reactions,type iii(imune complex-mediated)
    IIIÇü
  • hypersensitivity reactions,type iv(cell-mediated)
    IVÇü
  • hypersensitivity vasculitis
    °ú¹Î¼º Ç÷°ü¿°.
  • hypersensitivity, Jones-Mote
    ÁÔ½º-¸ðÆ® °ú¹Î¹ÝÀÀ
  • hypersensitivity, antibody-mediated
    Ç×ü¸Å°³ °ú¹Î¹ÝÀÀ
  • hypersensitivity, atopic
    ¾ÆÅäÇǼº °ú¹Î¹ÝÀÀ
  • hypersensitivity, cell-mediated
    ¼¼Æ÷¸Å°³ °ú¹Î¹ÝÀÀ
  • hypersensitivity, cellular
    ¼¼Æ÷¼º °ú¹Î¹ÝÀÀ
  • hypersensitivity, contact
    Á¢Ã˼º °ú¹Î¹ÝÀÀ
  • hypersensitivity, delayed-type
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • hypersensitivity, immediate-type
    Áï½ÃÇü °ú¹Î¹ÝÀÀ
  • hypersensitivity, penicillin
    Æä´Ï½Ç¸° °ú¹Î¹ÝÀÀ
  • hypersensitivity, poison ivy
    ¿Ì °ú¹Î¹ÝÀÀ
  • hypersensitivity, pollen
    ²É°¡·ç °ú¹Î¹ÝÀÀ, ²É°¡·ç ¾Ë·¹¸£±â
  • hypersensitivity, tuberculin
    Åõº£¸£Ä𸰠°ú¹Î¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • delayed hypersensitivity
    Áö¿¬Çü°ú¹ÎÁõ.
  • delayed type hypersensitivity
  • delayed-type hypersensitivity
    Áö¿¬Çü °ú¹Î¹ÝÀÀ
  • denervation hypersensitivity
    ½Å°æÁ¦°Å¼º °ú¹ÎÁõ(ãêÌèð¶ËÛàõΦÚÂñø).
  • denervation hypersensitivity test
    bethanecholÅ»½Å°æ°ú¹Î ¹ÝÀÀ°Ë»ç
  • dermal hypersensitivity
    ÇǺΰú¹Î¹ÝÀÀ
  • gluten hypersensitivity
    ±Û·çÅÙ°ú¹Î¹ÝÀÀ
  • hypersensitivity
    °ú¹Î¼º
  • hypersensitivity
    °¨°¢°ú¹Î¼º
  • hypersensitivity =hypersensitiveness
    °ú¹Î¼º, °ú¹ÎÁõ.
  • hypersensitivity angitis
    °ú¹Î¼º ¸Æ°ü¿°.
  • hypersensitivity angitis
    °ú¹Î¼º Ç÷°ü¿°(ΦÚÂàõ úìηæú)
  • hypersensitivity disorders
    °ú¹Î¼º Áúȯ(ΦÚÂàõ òðü´)
  • hypersensitivity myocarditis
    °ú¹Î¼º ½É±Ù¿°.
  • hypersensitivity reaction
    °ú¹Î¹ÝÀÀ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • round pneumonia
    ¿øÇüÆó·Å
  • secondary pneumonia
    ¼Ó¹ß¼ºÆó·Å
  • septic pneumonia
    ÆÐÇ÷¼ºÆó·Å
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DCH delayed cutaneous hypersensitivity; Diploma in Child Health
DH daily habits; day hospital; dehydrocholate; dehydrogenase; delayed hypersensitivity; dermatitis herp...
DHR delayed hypersensitivity reaction; Department of Human Resources
DHS delayed hypersensitivity; diabetic hyperosmolar state; duration of hospital stay; dynamic hip screw
DSHR delayed skin hypersensitivity reaction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
DCH Delayed cutaneous hypersensitivity
DH Delayed hypersensitivity
DHS Delayed hypersensitivity
DTH Delayed hypersensitivity
DHR Delayed hypersensitivity reactions
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • influenzal viral pneumonia
    ÀÎÇ÷翣ÀÚ Æó·Å
    ÀÎÇ÷翣ÀÚ¿¡ °É·Á ÀúÇ×·ÂÀÌ ÀúÇϵǾúÀ» ¶§ ±âµµ¿¡ ÀÖ´ø ¼¼±ÕÀÌ Áõ½ÄµÇ¾î ÀϾ´Â Æó·Å. ÀÌ¿Í °°ÀÌ 2Â÷ °¨¿°À» ÀÏÀ¸Å°´Â ¼¼±ÕÀº Æ÷µµ ±¸±Õ , Æó·Å ±¸±Õ , ¿¬¼â ±¸±Õ , ÀÎÇ÷翣ÀÚ ±Õ , Æó·Å °£±Õ µîÀÌ´Ù. º»ÁõÀÇ ÇÕº´·üÀº À¯Çà¿¡ µû¶ó Å« Â÷°¡ ÀÖÀ¸¸ç ¿¬·ÉÀûÀ¸·Î´Â ³ëÀÎÀÇ °æ¿ì¿¡ ³ô´Ù. Áõ¼¼´Â ÀÎÇ÷翣ÀÚÀÇ °í¿­ÀÌ 2¡­3ÀÏÀÌ µÇ¾îµµ ³»¸®Áö ¾Ê°í, ¶Ç´Â ÀÏ´Ü ³»·È´ø ¿­ÀÌ ´Ù½Ã »ó½ÂÇϸ鼭 È£Èí °ï¶õµµ ´õ¿í ½ÉÇØÁø´Ù. ÀÔ¼úÀ̳ª ¼Õ³¡Àº Â÷°¡¿öÁö°í ûÀÚ»öÀ» ¶í´Ù. ±âħ°ú ´ãµµ ¸¹À¸¸ç, ÈäºÎÀÇ Ã»Áø , ŸÁøÀ̳ª X¼± °Ë»ç¿¡¼­ Æó·ÅÀÇ ¼Ò°ßÀÌ Áõ¸íµÈ´Ù. Ä¡·á´Â 2Â÷ °¨¿°±Õ¿¡ ÀûÀÀµÇ´Â Ç×»ý ¹°ÁúÀ» ¾²´Â ¿Ü¿¡ ÀÏ¹Ý Æó·ÅÀÇ Ä¡·á¿¡ ÁØÇÑ´Ù. ³ëÀÎÀÇ °æ¿ì´Â »ç¸Á·üÀÌ ³ôÀ¸¸ç, ¶ÇÇÑ ÀÎÇ÷翣ÀÚ·Î »ç¸ÁÇÏ´Â »ç¶÷ÀÇ ¾à 80 %´Â Æó·ÅÀÇ ÇÕº´ ¶§¹®ÀÌ´Ù.
  • interstitial pneumonia
    °£Áú¼º Æó·Å
  • migratory pneumonia
    À¯ÁÖ Æó·Å
  • mycotic pneumonia
    Áø±Õ¼º Æó·Å.
  • plasma cell pneumonia
    ÇüÁú ¼¼Æ÷¼º Æó·Å
  • pneumonia
    Æó·Å
    1. ÆóÀÇ ¿°Áõ. ÇÕº´ÁõÀ» °¡Áø ÆóÀÇ ¿°Áõ. 2. Æó¿¡ »ý±â´Â ¿°Áõ. º´¸®ÇغÎÇÐÀûÀ¸·Î ÆóÀÇ ´ë¿± ÀüºÎ¿¡ ¿°ÁõÀÌ ÆÛÁø ´ë¿±¼º Æó·Å°ú, ¼Ò¿± ´ÜÀ§¿¡ ÇÑÁ¤µÈ ¼Ò¿±¼ºÆó·ÅÀ¸·Î ³ª´µ¸ç, º´¿øÃ¼¿¡ µû¶ó¼­µµ ¼¼±Õ¼º Æó·Å°ú ¹ÙÀÌ·¯½º¼º Æó·Å, ¾Ë·¹¸£±â¼º Æó·Å µîÀ¸·Î ³ª´¶´Ù. ¡¼´ë¿±¼º Æó·Å¡½ Å©·çÇÁ¼º Æó·ÅÀ̶ó°íµµ Çϸç, ¿øÀÎÀº ´ëºÎºÐÀÌ Æó·Å ±¸±ÕÀÌ´Ù. ¶§·Î´Â Æó·Å °£±Õ, Æ÷µµ»ó ±¸±Õ, ¿¬¼â ±¸±Õ¿¡ ÀÇÇÏ´Â °Íµµ ÀÖ´Ù. Áõ¼¼´Â ¿ÀÇÑ, ÀüÀ²À» ¼ö¹ÝÇÑ ¹ß¿­ ¿Ü¿¡ ±âħ, ÈäÅë, ³ì»ö °¡·¡, È£Èí °ï¶õ, Ä¡¾Æ³ëÁ¦ µîÀ̸ç, ûÁøÇϸé È¯ÃøÀÇ Æó¾ß´Â È£ÈíÀ½ÀÌ ¾àÇϰí ÀÛÀº ¼öÆ÷À½, ±â°üÁöÀ½ µîÀÌ µé¸°´Ù. X¼± »çÁøÀ¸·Î´Â ÀÌȯµÈ Æó¿±¿¡ ÀÏÄ¡µÈ °æ°è°¡ ¶Ñ·ÇÇÑ À½¿µÀ» ÀÎÁ¤ÇÒ ¼ö ÀÖ´Ù. Ä¡·á´Â Ç×»ý ¹°Áú, ƯÈ÷ ¿øÀÎ ±Õ¿¡ ´ëÇØ °¡Àå À¯È¿ÇÑ °ÍÀ» »ç¿ëÇÑ´Ù. È£Èí °ï¶õÀÌ ½ÉÇÏ¸é »ê¼Ò ÈíÀÔ, ½ÉÀåÀÌ ¼è¾àÇÏ¸é °­½ÉÁ¦¸¦ »ç¿ëÇÏ°í ´ëÁßÀûÀ¸·Î ÁøÅëÁ¦, ÁøÇØÁ¦, ÇØ¿­Á¦¸¦ »ç¿ëÇÑ´Ù. ¡¼±â°üÁö Æó·Å¡½ ±â°üÁöÀÇ ¿°ÁõÀÌ ³»ºÎ±îÁö ÆÛÁ®Æó Á¶Á÷¿¡ À̸£·¯ ÀϾ´Â °ÍÀ¸·Î, ¿øÀÎ ±ÕÀº Æó·Å ±ÕÀ̳ª ±× ¹ÛÀÇ È­³ó±ÕÀÌ´Ù. Áõ¼¼´Â º´¼ÒÀÇ Å©±â³ª ¿øÀÎ ±Õ¿¡ µû¶ó ´Ù¸£Áö¸¸, ±âħ, ¹ß¿­, ¹ßÇÑ, È£Èí °ï¶õ, Ä¡¾Æ³ëÁ¦, ÈäÅë µîÀÌ ÀÖ´Ù. X¼± »çÁøÀ¸·Î´Â °æ°è°¡ ¼±¸íÇÏÁö ¸øÇÑ ºÒ±ÔÄ¢ÀûÀÎ ÀÛÀº À½¿µÀÌ »êÀçÇÑ´Ù. ûÁøÇϸé È¯Ãø¿¡ ¼öÆ÷À½ µîÀÇ ÀâÀ½ÀÌ µé¸°´Ù. Ä¡·á´Â ¾ÕÀÇ ´ë¿±¼º Æó·Å°ú °°´Ù. ¡¼¹ÙÀÌ·¯½º¼º Æó·Å¡½ ¿ø¹ß¼º ÀÌÇü Æó·Å, ÀÎÇ÷翣ÀÚ Æó·Å, ¾Þ¹«º´¹ÙÀÌ·¯½º Æó·Å, ¾Æµ¥³ë ¹ÙÀÌ·¯½º Æó·Å µîÀÌ ÀÖ´Ù. ¿ø¹ß¼º ÀÌÇü Æó·ÅÀº °æ¹ÌÇÑ ¹ß¿­°ú ½ÉÇÑ ±âħ, °¡·¡, ÈäÅëÀÌ ÁÖ¿ä Áõ¼¼ÀÌ´Ù. X¼± »çÁø¿¡¼­´Â Æó¹®ºÎ¿¡¼­ ¸»ÃÊ·Î ÇâÇÏ´Â ¿¯Àº ±ÕÀÏÇÑ À½¿µÀÌ Æ¯Â¡À̸ç ÇÏÆó¾ß¿¡¼­ º¼ ¼ö ÀÖ´Ù. Áø´Ü¿¡´Â ÀûÇ÷±¸ ÇÑ·© ÀÀÁý ¹ÝÀÀÀ̳ª ¿¬¼â ±¸±Õ MG ÀÀÁý ¹ÝÀÀÀÌ À¯È¿ÇÏ´Ù. Ä¡·á¿¡´Â Åׯ®¶ó»çÀÌŬ¸°
  • pneumonia,in immunocompromised host
    ¸é¿ª ±â´É ÀúÇÏ ¼÷ÁÖÀÇ
  • postoperative pneumonia
    ¼ö¼úÈÄ Æó·Å, ¼úÈÄ Æó·Å
  • rheumatic pneumonia
    ·ù¸¶Æ¼½º¼º Æó·Å
  • rickettsial pneumonia
    ¸®ÄÉÄ¡¾Æ¼º Æó·Å
  • round pneumonia
    ¿øÇü Æó·Å
  • secondary pneumonia
    ¼Ó¹ß¼º Æó·Å
  • septic pneumonia
    ÆÐÇ÷¼º Æó·Å
  • serous pneumonia
    Àå¾×¼º Æó·Å
  • staphylococcal pneumonia
    Æ÷µµ ±¸±Õ¼º Æó·Å
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
immediate hypersensitivity reaction An immune response mediated by antibody, usually IgE, which occurs within minutes after a second encounter with an antigen, resulting in the release of histamine and subsequent swelling and vasodilation.
(05 Mar 2000)
tuberculin-type hypersensitivity A local or generalised response that begins 24 to 48 hours after exposure to an antigen.
See: cell-mediated reaction.
Synonym: contact hypersensitivity, delayed hypersensitivity, late reaction, tuberculin-type hypersensitivity.
(05 Mar 2000)
type III hypersensitivity reaction An immunologic category of diseases evoked by the deposition of antigen-antibody or antigen-antibody-complement complexes on cell surfaces, with subsequent involvement of breakdown products of complement, platelets, and polymorphonuclear leukocytes, and development of vasculitis; nephritis is common. Arthus phenomenon and serum sickness are classic examples, but many other disorders, including most of the connective tissue disease's, may belong in this immunologic category; immune complex disease's can also occur during a variety of disease's of known aetiology, such as subacute bacterial endocarditis.
See: autoimmune disease.
Synonym: immune complex disorder, type III hypersensitivity reaction.
(05 Mar 2000)
food hypersensitivity Gastrointestinal disturbances, skin eruptions, or shock due to allergic reactions to allergens ingested in food.
(12 Dec 1998)
acute interstitial pneumonia A severe and usually fatal form of pneumonia occurring primarily in infants usually considered a form of hypersensitivity pneumonitis.
(05 Mar 2000)
alcoholic pneumonia Pneumonia occurring in patient with alcoholism, usually after a period of intoxication with stupor, resulting in aspiration.
(05 Mar 2000)
anthrax pneumonia A form of anthrax acquired by inhalation of dust containing Bacillus anthracis; there is an initial chill followed by pain in the back and legs, rapid respiration, dyspnea, cough, fever, rapid pulse, and extreme cardiovascular collapse.
Synonym: anthrax pneumonia, ragpicker's disease, ragsorter's disease, rag-sorter's disease, wool-sorter's pneumonia, woolsorter's disease, wool-sorter's disease.
(05 Mar 2000)
apex pneumonia Apical pneumonia, pneumonia of the apex or apices.
(05 Mar 2000)
aspiration pneumonia <chest medicine> Refers to the inappropriate passage of food, water, stomach acid, vomit or another foreign material into the lungs. Aspiration, particularly involving gastric acid, will often result in a serious pneumonia.
(27 Sep 1997)
atypical pneumonia <chest medicine> This refers to a type of pneumonia that does not follow the typical signs and symptoms of pneumonia. A number of different viral and bacterial agents have been identified which can cause this form of respiratory infection.
Examples include Chlamydia pneumonia, psittacosis, Mycoplasma, influenza A or B, adenovirus and Legionella. Antibiotics will be necessary in all but the mildest cases. Symptoms generally improve in less than 2 weeks.
(27 Sep 1997)
bacterial pneumonia Infection of the lung with any of a large variety of bacteria, especially Streptococcus pneumoniae(pneumococcus).
(05 Mar 2000)
bilious pneumonia Pneumonia following aspiration of gastric contents containing bile.
(05 Mar 2000)
bronchial pneumonia <chest medicine> A name given to an inflammation of the lungs which usually begins in the terminal bronchioles.
These become clogged with a mucopurulent exudate forming consolidated patches in adjacent lobules. The disease is frequently secondary in character, following infections of the upper respiratory tract, specific infectious fevers and debilitating diseases. In infants and debilitated persons of any age it may occur as a primary affection.
Synonym: bronchial pneumonia, bronchoalveolitis, bronchopneumonitis, lobular pneumonia.
(11 Jan 1998)
bronchiolitis obliterans organizing pneumonia A disease formerly considered a form of interstitial pneumonia. Its aetiology is obscure but it may be associated with toxic fumes, infection, and connective tissue disease. Clinical symptoms include cough, dyspnea and influenza-like symptoms with the development of the usual interstitial pneumonia in many cases. Obstructive symptoms are limited to smokers. There are patchy polypoid masses of intra-alveolar granulation tissue in small airway lumina and alveolar ducts. "organizing" refers to unresolved pneumonia (in which the alveolar exudate persists and eventually undergoes fibrosis) in which fibrous tissue forms in the alveoli.
(12 Dec 1998)
bronchiolitis obliterans with organizing pneumonia Bronchiolitis fibrosa obliterans complicated by pneumonia with organization.
Acronym: BOOP
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á